Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.

Advances in radiation oncology·2026

Same author

Impact of a Multidisciplinary Palliative Radiation Therapy Clinic on Patient Care.

Advances in radiation oncology·2026

Same author

A progeria syndrome links DNA hypermethylation to age-related pathology.

Nature genetics·2026

Same author

What Circulating Titanium May Be Telling Us After Total Ankle Arthroplasty.

Foot & ankle international·2026

Same author

Efficacy and safety of metastasis-directed therapy for oligometastatic cancer: a systematic review and meta-analysis of randomized controlled trials.

Radiation oncology (London, England)·2026

Same author

Clear Cell Chondrosarcoma With Somatic VHL Inactivation: A Case Report With Integrated Genomic and Transcriptomic Analysis.

Genes, chromosomes & cancer·2026

Same journal

Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same journal

Genomic Characterization of Classic Adamantinoma, Osteofibrous Dysplasia, and Osteofibrous Dysplasia-like Adamantinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same journal

Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid Neoplasms.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same journal

Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption and Dismal Prognosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same journal

Co-Existent Endometrial and Fallopian Tube Carcinoma, Molecular and Pathological Features for Risk Stratification.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same journal

RUNX2 Rearrangement as a Recurrent Molecular Event and Diagnostic Marker in Salivary Gland Keratocystoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 20, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas.

Tatiana Tvrdik¹, Sandra Gjorgova Gjeorgjievski¹, Philip Wong²

¹Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc

|July 21, 2024

Summary

This summary is machine-generated.

Infarct-associated sarcomas of bone show high genomic complexity and homologous recombination deficiency (HRD). These rare bone cancers may have distinct genetic profiles compared to conventional osteosarcoma, particularly regarding TP53 mutations and CDKN2A/B deletions.

Keywords:

CDKN2A/B deletion bone infarct chromothripsis genomic instability homologous recombination deficiency intraosseous sarcoma

More Related Videos

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jun 20, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Area of Science:

Oncology
Genomics
Skeletal Biology

Background:

Infarct-associated sarcomas are rare bone tumors with poorly understood genetic characteristics.
High-grade undifferentiated pleomorphic sarcomas (UPS) of bone are typically treated with surgery and chemotherapy.

Purpose of the Study:

To conduct a detailed clinicopathologic and genomic analysis of intraosseous sarcomas arising from bone infarcts.
To understand the genetic landscape and identify potential therapeutic targets in these rare bone sarcomas.

Main Methods:

Next-generation sequencing (523 genes) and whole-genome SNP Microarray (OncoScan CNV) for mutation and copy number alteration analysis.
Assessment of genomic instability using homologous recombination deficiency (HRD) metrics.
Fluorescence in situ hybridization (FISH) and immunohistochemistry for validation.

Main Results:

Genomic analysis revealed significant complexity and high HRD scores (32-57) in all 6 cases.
Common alterations included chromosome 12 abnormalities (4/6 cases), homozygous CDKN2A/B deletion (6/6 cases), and MDM2 amplification (2/6 cases).
Notable mutations included H3-3A, HRAS, DNMT3A, NF2, PIK3CA, POLE, and TP53.

Conclusions:

High-grade infarct-associated sarcomas of bone exhibit high genomic complexity and HRD, similar to osteosarcoma.
These sarcomas may differ from conventional osteosarcoma with potentially fewer TP53 mutations and more frequent CDKN2A/B deletions.
The distinct mutation spectrum suggests unique disrupted pathways in infarct-associated bone sarcomas.